Metin Konuş

Metin Konuş

Auto-generated profile, based on publicly available information

Metin Konuş

Van Yüzüncü Yıl Üniversitesi

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
MKMetin Konus
Metin Konus
DÇDoğan Çetin
Doğan Çetin
NKNurhan Didem Kızılkan
Nurhan Didem Kızılkan
CYCan Yılmaz
Can Yılmaz
CFCeylan Fidan
Ceylan Fidan
SASevki Arslan
Sevki Arslan

20 May 2020 in ChemistrySelect
Verified
Journal Article
Closed access
PDF file
MKMetin Konus
Metin Konus
DÇDoğan Çetin
Doğan Çetin
CYCan Yılmaz
Can Yılmaz
SASevki Arslan
Sevki Arslan
DMDogukan Mutlu
Dogukan Mutlu
AKArif KIVRAK
Arif KIVRAK

1 January 2022 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AKAslıhan Kurt-Kızıldoğan
Aslıhan Kurt-Kızıldoğan
NANeslihan Akarsu
Neslihan Akarsu
ÇOÇiğdem OTUR
Çiğdem OTUR
AKArif KIVRAK
Arif KIVRAK
NANevroz Aslan-Ertas
Nevroz Aslan-Ertas
NSNevzat Sahin
Nevzat Sahin
Background: Marine actinomycetes are among indispensable sources of natural bioactive compounds with unique antimicrobial and anti-cancer activities. Objective: Herein, it was aimed to elucidate the bioactive potential of a marine-derived Streptomyces ovatisporus S4702T, isolated previously. Methods: Streptomyces ovatisporus S4702T was cultured in N-Z Amine broth, and extraction was carried out using different organic solvents. Bioassay-guided purification was followed by chemical characterization using NMR and LC-MS/MS. The compound was then evaluated for its antibacterial, antioxidant and cytotoxic activities. Results: Etyl acetate extracts gave the highest antibacterial activity, and chemical characterization of this extract indicated the formula as C15H29O5N3 and the corresponding possible molecular structure as 4H-chromen-4-one derivative. It was found highly potent against Bacillus subtilis ATCC 6633 (MIC: 0.25 μg ml-1) and Micrococcus luteus ATCC 9341 (MBC: 0.5 μg ml-1). It has no remarkable antioxidant activity, but a higher EC50 value and less cytotoxicity against normal cells. The EC50 values of this chromen derivative were found as 9.68 μg ml-1 for human colon carcinoma, 9.93 μg ml-1 for human prostate adenocarcinoma and 25.5 μg ml-1 for human embryonic kidney cells. Conclusion: Overall, the presented 4H-chromen-4-one derivative is a remarkable bioactive compound with potent antibacterial and cytotoxic activity. With its high bioactive potential, it is proposed as a good candidate in medicine.

11 June 2021 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
CYCan Yılmaz
Can Yılmaz
SASevki Arslan
Sevki Arslan
DMDogukan Mutlu
Dogukan Mutlu
MKMetin Konus
Metin Konus
AKAbdussamet Kayhan
Abdussamet Kayhan
AKArif KIVRAK
Arif KIVRAK
Background: Indole based heterocyclic compounds plays important roles in pharmaceutical chemistry due to their unexpected biological and pharmacological properties. Objective: Herein, we describe novel biological properties (antioxidant, antimicrobial and anticancer) of 3-bromo-1-ethyl-1H-indole (BEI) structure. Method: BEI was synthesized from 1-Methyl-2-phenylindole and N-bromosuccinimide and were characterized by using 1H and 13C NMR. 1H and 13C NMR. Cytotoxity was determined by MTT assay. Apoptosis analysis of BEI was determined by Arthur™ imagebased Cytometer. Different methods was applied to assessed the antioxidant activity of BEI. Molecular docking studies were conducted to determine the interactions of bonding between GST isozymes and BEI. Results: According to the antioxidant and antimicrobial activity assays, BEI compound showed less total antioxidant activity compared to trolox standard whereas it showed moderate antimicrobial activity against Aspergillus niger and Phytophora eryhtrospora. Notably, BEI compound demonstrated substantial selective cytotoxicity for the first time towards cancer cell lines and there existed significant decrease in the percentage of live cells treated with BEI, in comparison to the control ones. Interestingly, BEI exhibited a promising glutathione S-transferase isozymes inhibition. Conclusion: The results of this study suggest that BEI seems to be a promising molecule to be used in design of new anticancer agents that provide superiority to present commercial anticancer drugs.

1 April 2019 in Letters in Organic Chemistry
Verified
Journal Article
Closed access
PDF file
MKMetin Konus
Metin Konus
SASelahattin Aydemir
Selahattin Aydemir
CYCan Yilmaz
Can Yilmaz
AKArif KIVRAK
Arif KIVRAK
AKAslıhan Kurt-Kızıldoğan
Aslıhan Kurt-Kızıldoğan
PAPembegül Uyar Arpacı
Pembegül Uyar Arpacı
5-bromo-2-(prop-2-yn-1-yloxy)benzaldehyde (compound 3) and 3,5-di-tert-butyl-2-(prop-2- yn-1-yloxy)benzaldehyde (compound 5) were synthesized via nucleophilic substitution reactions. Compound 5 showed higher antioxidant capacity with respect to compound 3 in all the four different antioxidant activity methods used. Moreover, in phosphomolybdenum assay, compound 5, with 1.1 proportion value, showed almost the same total antioxidant capacity compared to universal trolox standard. Furthermore, Broth microdilution method and agar disc diffusion tests demonstrated that the same compound also exhibited good antibacterial activity towards the bacteria Bacillus subtilis. Finally, both of the benzaldehyde compounds showed high antifungal activity against Aspergillus niger. In this study, compound 5 (IC50: 54.3 µg/ml) showed significant cytotoxic activity against breast adenocarcinoma cell line MCF-7 with respect to compound 3 (IC50: 173.4 µg/ml).

1 January 2021 in Russian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
EKE. Kavak
E. Kavak
MAM.A.S. Algso
M.A.S. Algso
MKM. Konus
M. Konus
CYC. Yılmaz
C. Yılmaz
ALA. Lazoğlu
A. Lazoğlu
AKArif KIVRAK
Arif KIVRAK
2,3-Dialkynylthiophene derivatives were synthesized by using regio- and stereocontrolled Pd-catalyzed Sonogashira coupling and desilylation reactions. The synthesized compounds were analyzed in silico for their pharmacokinetic parameters, general toxicity, and drug scores. In particular, 3-ethynyl-2-(phenylethynyl)thiophene and 3-ethynyl-2-[(4-methylphenyl)ethynyl]thiophene were found to have relatively high drug scores and low toxicities. The antioxidant activity of the title compounds were evaluated by five different assays. 3-Ethynyl-2-(naphthalen-1-ylethynyl)thiophene displayed significant reducing and free radical scavenging activities.